VIREO GROWTH INC.

Profile

Company Names

VIREO GROWTH INC.
GOODNESS GROWTH HOLDINGS, INC.
VIREO HEALTH INTERNATIONAL, INC.

Addresses

1330 LAGOON AVENUE, 4TH FLOOR, MINNEAPOLIS, MN 55408

207 SOUTH 9TH STREET, MINNEAPOLIS, MN 55402

Phone Numbers

(612) 999-1606
612-999-1606
844 484-7366
604-617-5421

 

Entity Type:

CORPORATION

Industry:

OTHER, PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

BRITISH COLUMBIA, CANADA

Total Amount Raised:

$380,853,419.00

Number of Funding Rounds:

13
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
13
2026-06-18 
$1,149,959.00 
$1,149,959.00 
$0.00 
Equity, Debt 
12
2026-06-05 
$13,662,648.00 
$13,662,648.00 
$0.00 
Debt 
11
2026-04-08 
$127,800,000.00 
$195,800,000.00 
$68,000,000.00 
Equity 
10
2026-04-01 
$50,612,571.00 
$50,612,571.00 
$0.00 
Equity 
9
2025-12-30 
$1,672,591.00 
$1,672,591.00 
$0.00 
Equity 
8
2025-10-10 
$61,996,221.00 
$61,996,221.00 
$0.00 
Equity 
7
2025-07-07 
$10,000,000.00 
$10,000,000.00 
$0.00 
Debt 
6
2024-12-23 
$80,960,547.00 
$80,960,547.00 
$0.00 
Equity 
5
2024-11-01 
$10,000,000.00 
$10,000,000.00 
$0.00 
Debt 
4
2024-07-31 
$5,387,500.00 
$5,387,500.00 
$0.00 
Equity 
3
2023-04-28 
$0.00 
$10,000,000.00 
$10,000,000.00 
Equity 
2
2020-03-09 
$2,660,049.00 
$5,976,474.00 
$3,316,425.00 
Equity 
1
2019-03-18 
$14,951,333.00 
$14,951,333.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEPHEN 
 
DAHMER 
EXECUTIVE OFFICER
JENNIFER 
 
DUEY 
EXECUTIVE OFFICER
CHELSEA 
 
GRAYSON 
DIRECTOR
ERIC 
 
GREENBAUM 
EXECUTIVE OFFICER
CHRIS 
 
HAGEDORN 
DIRECTOR
ARI 
 
HOFFNUNG 
EXECUTIVE OFFICER, DIRECTOR
ROSS 
 
HUSSEY 
DIRECTOR
TYSON 
 
MACDONALD 
EXECUTIVE OFFICER
VICTOR 
E. 
MANCEBO 
DIRECTOR
JUDD 
 
NORDQUIST 
DIRECTOR
SHAUN 
 
NUGENT 
EXECUTIVE OFFICER
PATRICK 
 
PETERS 
EXECUTIVE OFFICER
AMBER 
 
SHIMPA 
DIRECTOR, EXECUTIVE OFFICER
MICHAEL 
 
STEINER 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity, Debt 
2026-06-18 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2026-06-05 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2026-04-08 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2026-04-01 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-12-30 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-10-10 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2025-07-07 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-12-23 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2024-11-01 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-07-31 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-04-28 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-04-28 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-03-09 
D/A
OTHER 
 
$5,000,001 - $25,000,000 
Equity 
2019-03-18 
D
OTHER 
 
$5,000,001 - $25,000,000 
Equity 
2019-03-18 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
GT SECURITIES, INC.
CANACCORD GENUITY CORP.
NONE
CANACCORD GENUITY LLC